Dedicated transcatheter solution to treat tricuspid valve regurgitation
This article was originally published in Start Up
4Tech Inc. has developed a dedicated transcatheter system to treat tricuspid regurgitation. ItsTriCinch applies tension to an anchor placed on the annulus of the tricuspid valve, thus reducing the size of the native annulus and limiting the amount of blood that can backflow through the valve.
You may also be interested in...
Novartis has long championed the idea of making Sandoz an autonomous unit within the Swiss originator while stopping short of carving out the business altogether. Rumors continue to swirl around a potential deal, which was discussed during the recent virtual Meet Novartis Management event.
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.